ExchangeDEX+
Buy CryptoMarketsSpotFuturesGOLDEarnEvent Center
More
Commodity Zero-Fee Gala
IRVING, Texas, Feb. 9, 2026 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicineIRVING, Texas, Feb. 9, 2026 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine

Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26

Author: AI Journal
Source: AI Journal
2026/02/09 21:46
2 min read
PoP Planet
P$0,01043+%0,48
CharacterX
CAI$0,0408+%0,79
MemeCore
M$1,43894+%6,24

IRVING, Texas, Feb. 9, 2026 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026.

Caris Life Sciences will host a conference call and live webcast at 3:30 p.m. CT (4:30 p.m. ET) to discuss the financial results.

Conference Call Details:

Date: Thursday, February 26, 2026
Time: 3:30 p.m. CT (4:30 p.m. ET)
Live Webcast: https://edge.media-server.com/mmc/p/49czfgs4

A replay of the webcast will be available shortly after the conclusion of the call on the Investor Relations section of the Caris Life Sciences website at CarisLifeSciences.com.

About Caris Life Sciences
Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Genome, Whole Exome and Whole Transcriptome Sequencing), advanced AI and machine learning, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies and high-performance computing provides a differentiated platform for developing the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development. 

Caris was founded with a vision to realize the potential of precision medicine to improve the human condition. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S. and other international markets. 

Caris Life Sciences Media:
Corporate Communications
CorpComm@CarisLS.com
214.294.5606

Investor Relations:
IR@CarisLS.com
917.689.3511

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/caris-life-sciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-302681818.html

SOURCE Caris Life Sciences

Market Opportunity
PoP Planet Logo
PoP Planet Price(P)
$0,01043
$0,01043$0,01043
+%0,28
USD
PoP Planet (P) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Hoskinson to Attend Senate Roundtable on Crypto Regulation

Hoskinson to Attend Senate Roundtable on Crypto Regulation

The post Hoskinson to Attend Senate Roundtable on Crypto Regulation appeared on BitcoinEthereumNews.com. Hoskinson confirmed for Senate roundtable on U.S. crypto regulation and market structure. Key topics include SEC vs CFTC oversight split, DeFi regulation, and securities rules. Critics call the roundtable slow, citing Trump’s 2025 executive order as faster. Cardano founder Charles Hoskinson has confirmed that he will attend the Senate Banking Committee roundtable on crypto market structure legislation.  Hoskinson left a hint about his attendance on X while highlighting Journalist Eleanor Terrett’s latest post about the event. Crypto insiders will meet with government officials Terrett shared information gathered from some invitees to the event, noting that a group of leaders from several major cryptocurrency establishments would attend the event. According to Terrett, the group will meet with the Senate Banking Committee leadership in a roundtable to continue talks on market structure regulation. Meanwhile, Terrett noted that the meeting will be held on Thursday, September 18, following an industry review of the committee’s latest approach to distinguishing securities from commodities, DeFi treatment, and other key issues, which has lasted over one week.  Related: Senate Draft Bill Gains Experts’ Praise for Strongest Developer Protections in Crypto Law Notably, the upcoming roundtable between US legislators and crypto industry leaders is a continuation of the process of regularising cryptocurrency regulation in the United States. It is part of the Donald Trump administration’s efforts to provide clarity in the US cryptocurrency ecosystem, which many crypto supporters consider a necessity for the digital asset industry. Despite the ongoing process, some crypto users are unsatisfied with how the US government is handling the issue, particularly the level of bureaucracy involved in creating a lasting cryptocurrency regulatory framework. One such user criticized the process, describing it as a “masterclass in bureaucratic foot-dragging.” According to the critic, America is losing ground to nations already leading in blockchain innovation. He cited…
Share
BitcoinEthereumNews2025/09/18 06:37
Travelzoo Q4 2025 Earnings Conference Call on February 19 at 11:00 AM ET

Travelzoo Q4 2025 Earnings Conference Call on February 19 at 11:00 AM ET

NEW YORK, Feb. 9, 2026 /PRNewswire/ — Travelzoo® (NASDAQ: TZOO): WHAT: Travelzoo, the club for travel enthusiasts, will host a conference call to discuss the Company
Share
AI Journal2026/02/10 01:46
TradFi vs. Crypto: Bybit Launches 300,000 USDT Trading Challenge as Copy Trading Gains Momentum in Volatility

TradFi vs. Crypto: Bybit Launches 300,000 USDT Trading Challenge as Copy Trading Gains Momentum in Volatility

DUBAI, UAE, Feb. 9, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is calling traders across the TradFi and crypto
Share
AI Journal2026/02/10 01:45